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                                           INTRODUCTION  
“For all the happiness that mankind can gain 
It is not in pleasure but in relief from pain” 
- JOHN DYRDEN 
Pain is a fundamental biological phenomenon.  
Pain is an “unpleasant sensory and emotional experience that 
occurs in response to tissue damage’’. It is always underestimated and 
under treated. The relief of pain during surgery is the main part of 
anaesthesia. 
Pain is perhaps the most feared symptom of disease and man has 
tried his level best to discover methods to relieve pain. 
Pain relief is provided by various methods like oral medication, 
nerve blocks but adequate pain relief is provided by interrupting the 
transmission of pain. 
 Peripheral nerve blocks provide longer and more localized pain 
relief than systemic opioids, non-steroidal anti-inflammatory drugs. 
Regional anaesthetic technique provides anaesthesia as well as analgesia 
than general anaesthesia as it requires an alternative technique to 
provide analgesia in the post-operative period. 
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The mode of pain relief should be such that it is technically less 
harmful, has minimal side effects, makes the surgeon comfortableand 
has extended post-operative comfort and also cost effective. In modern 
medicine, postoperative analgesia is considered an integral part of the 
anaesthetic management. 
Recently regional anaesthetic techniques including peripheral 
nerve blocks are commonly used in the management of perioperative 
pain because of their distinct advantages over general anaesthesia and 
central neuraxial anaesthesia. 
Pain relief with peripheral nerve block is devoid of adverse 
effects like somnolence, haemodynamic instability, nausea, vomiting   
and voiding difficulties inherent to general anaesthesia and central 
neuraxial anaesthesia. 
All patients require adequate pain relief during the first 24 hours 
postoperatively. Post-operative pain can be treated with drugs like 
opioids or non-steroidal anti-inflammatory agents. 
Usually surgeons are reluctant to use NSAIDs so soon after any 
type of procedure because of fear of bleeding complications. Opioids 
have many well-known undesirable effects, like nausea and vomiting 
which can occur postoperatively due to surgery or anaesthesia itself.  
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Pain following thyroidectomy is of shorter duration with 
moderate intensity. But even then most of the patients require analgesics 
like opioids or non-opioid agents. 
But thyroid surgery itself is associated with high incidence of 
post-operative nausea and vomiting, so it is better to avoid analgesics 
that cause nausea and vomiting like opioids, nefopam etc. 
Other methods to reduce postoperative pain following thyroid 
surgeries include wound infiltration with local anaesthetics, cervical 
plexus block which includes both superficial and deep cervical plexus 
block. 
Among this bilateral superficial cervical plexus block is 
commonly used due to its efficacy and simplicity in performing the 
technique and without much complications. Deep cervical plexus block 
is an alternative technique but associated with serious complications 
like phrenic nerve palsy. 
The present study was done to evaluate the analgesic efficacy of 
preoperative bilateral superficial cervical plexus block for thyroid 
surgeries. 10 ml of 0.25% bupivacaine is given bilaterally in study 
group and 10 ml of normal saline in control group. 
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                                   AIM OF THE STUDY 
To evaluate the analgesic efficacy of preoperative bilateral 
superficial cervical plexus block in patients undergoing thyroidectomy 
under general anaesthesia. 
The analgesic efficacy of the block is assessed in terms of: 
- Total dose of Intraoperative requirements of Fentanyl 
- Total dose of Postoperative requirements of Morphine  
- Postoperative side effects  
- Complications associated with the procedures 
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                                                HISTORY 
The doctrine of specific energies of the senses, proclaimed by 
Johannes P. Mueller (1801–58) in 1826 – that it is the nerves that 
determine what the mind perceives – opened up a new field of scientific 
thought  and  research into nerve function. This led directly to the theory 
that pain is a separate and distinct sense, formulated by Moritz S. Schiff 
(1823–96) in 1858.  
Sir Francis Rynd delivered morphine solution into the nerve in 
order to relieve pain due to intractable neuralgia and this was the first 
documented nerve block. 
Sir Francis Rynd (1801 – 61), delivered the solution by means 
of gravity through a cannula. The first use of a syringe and hypodermic 
needle was in 1855, by Alexander Wood (1817–84), Edinburgh.  
Halsted and Hall described the injection of cocaine into 
peripheral sites for minor surgeries in 1880s. 
Cervical plexus blocks were first performed by Halsted at 
Bellevue Hospital in New York in 1884. Halsted performed many 
experiments with the new anesthetic cocaine, including an experiment 
showing that excellent surgical anesthesia could be obtained by 
injecting the nerve trunks in the neck.  
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The first description of cervical plexus block for surgical 
anesthesia was published in Germany in 1912 by Kappis, who 
advocated a posterior approach. In 1914, Heidenhein introduced 
the lateral approach to cervical plexus block. These techniques were 
popularized in France by Pauchet and in America by Labat. 
Methods of cervical plexus block: 
• Deep  
• Intermediate 
• Superficial 
Deep cervical plexus block – (Moore or Winnie ) 
 C2- C4 transverse processes identified and the drug injected into 
deep (prevertebral) cervical region. Can be done by either three separate 
injections or as single one. 
Intermediate cervical plexus block – 
 Here drug is injected deep to subcutaneous layer but above deep 
cervical fascia. 
Superficial cervical plexus block – (Murphy and Scott) : It is the 
simplest technique which involves subcutaneous injection of drug at the 
midpoint of sternocleidomastoid muscle along the  posterior border . 
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                    SUPERFICIAL CERVICAL PLEXUS BLOCK 
Cervical plexus: 
The cervical plexus is formed by the union of anterior rami of 
upper 4 cervical nerves. 
 The cervical plexus is formed as loops which are 3 in number 
• C1-2 
• C2-3 
• C3-4 with another loop (C4-5) to connect with brachial plexus.  
They are located on the levator scapulae and scalenus medius 
muscles under the cover of sternocleidomastoid. 
C1 does not have any cutaneous innervations. 
 
Cervical plexus branches: 
• Communicating branches- to the cervical sympathetic chain, 
Hypoglossal nerve, Vagus. 
• Superficial branches which supply cutaneous fibres to neck. 
• Deep branches which supply the neck muscles. 
• Phrenic nerve provides the motor supply to diaphragm. 
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The Superficial Cervical Plexus is divided into 4 terminal branches : 
• Ascending -   greater auricular nerve(C2,3) 
                              lesser occipital nerve (C2) 
• Transverse  - (C2,3) anterior cutaneous nerve to neck 
• Descending -(C3,4) supraclavicular nerves – medial 
intermediate and lateral branches. 
 
Lesser occipital nerve: 
                 This ascending branch of superficial cervical plexus hooks 
around spinal accessory nerve and then it ascends along the posterior 
border of sternocleidomastoid. It pierces the deep fascia in the posterior 
triangle of neck, where it splits up into 3 branches. 
• Auricular 
• Mastoid 
• Occipital 
 
Great auricular (C2, C3) nerve:- 
It is the largest cutaneous branch. It hooks around the midpoint of 
the posterior border of sternocleidomastoid muscle, and then it passes 
across the muscle in the direction of angle of the mandible. 
On the same muscle it divides into 3  branches. 
  
 
SUPERFICIAL CERVICAL PLEXUS BLOCK: ANATOMY AND  
TECHNIQUE 
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• Auricular - sensory supply to lower 2/3rds of the medial aspect of 
external ear and the lateral surface of the lobule. 
• Mastoid - It supplies the skin overlying the mastoid. 
• Facial - It supplies the skin overlying masseter muscle and 
parotid gland. 
 
Anterior cutaneous nerve of the neck(C2,3)- 
        It arises at the posterior border of sternocleidomastoid below the 
great auricular nerve and then its course turns horizontally forwards on 
the muscle, deep to external jugular vein. 
 
Supraclavicular nerves (C3,4)- 
      It has three branches:  
• Medial 
• Intermediate 
• Lateral 
These supply the skin over the upper sternum, the upper chest wall, 
and the upper deltoid. 
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SUPERFICIAL CERVICAL PLEXUS BLOCK :-  
Landmark Technique    
Distribution of anaesthesia- 
 The superficial cervical plexus block results in anesthesia of the 
skin of the anterolateral aspect of neck and the anterior auricular, 
posterior auricular areas, and also skin overlying and immediately 
inferior to the clavicle on the chest wall. But it produces only sensory 
blockade while Deep Cervical Plexus block produces both sensory and 
motor blockade. 
Patient positioning- 
Place the patient in Supine position, with the head turned slightly 
away from block site. Ipsilateral arm is placed on patient’s side. The 
patient’s neck and upper chest should be exposed maximally so that the 
absolute length and position of the sternocleidomastoid can be assessed. 
Equipments- 
A tray with following equipments : 
• Sterile towels 
• 4”× 4” gauze pieces 
• 20-ml syringe  
• Marker pen, 
• Sterile gloves 
• 11/2” 25-gauge needle for block infiltration. 
  
 
 
SUPERFICIAL CERVICAL PLEXUS BLOCK, LANDMARK 
TECHNIQUE 
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LANDMARKS: 
• Chassaignac’s tubercle of C6. 
• Mastoid process. 
 
ANATOMIC LANDMARKS: 
 A line is drawn extending from the mastoid to C6 cervical 
vertebra. At the midpoint of the line which connects the mastoid process 
with Chassaignac’s tubercle of C6 transverse process the needle is 
inserted. This is the point where the branches of the superficial cervical 
plexus emerge behind the posterior border of the sternocleidomastoid 
muscle or simply the midpoint of posterior border of 
sternocleidomastoid muscle. 
TECHNIQUE: 
After painting and draping the parts, midpoint of posterior border 
of sternocleidomastoid muscle is identified. Local infiltration is given at 
the entry point. Then ten ml of solution is given subcutaneously in a fan 
shaped manner along the posterior border of sternocleidomastoid, 6 ml 
in up and down direction and 4ml just above the muscle horizontally to 
block all the 4 terminal branches . 
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      The main goal of this technique is to infiltrate the local 
anaesthetic subcutaneously and behind sternocleidomastoid. Deep 
needle insertion should be avoided.(should be less than 1-2cm).  
ULTRASOUND GUIDED TECHNIQUE: 
This technique is considered to be the most precise way of 
blocking the respective nerves.The primary goal of such technique is to 
deposit local anaesthetic in the vicinity of the sensory branches of the 
nerve roots C2, C3 and C4. 
 
Advantages: 
• Ability to ensure the spread of local anaesthetic in the correct 
plane. 
• Increase the success rate. 
• Avoid too deep needle insertion. 
• Inadvertent puncture of neighbouring structures. 
 
Both in-plane and out-of-plane approaches can be used. 
 
The sternocleidomastoid muscle forms a “roof” over the nerves of  
the superficial cervical plexus(C2-4).The roots combine to form the  
four terminal branches and emerge from behind the posterior border of 
the sternocleidomastoid. The plexus can be visualized as a small 
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collection of hypoechoic nodules (honeycomb appearance or 
hypoechoic oval structures) immediately deep or lateral to the posterior 
border of the sternocleidomastoid. 
LOCAL ANAESTHETIC OF CHOICE: 
                   The block requires 3-5ml for each redirection. So 10-15ml 
of local anaesthetic is needed in total. 
LOCAL 
ANAESTHETIC  
ONSET 
TIME(min) 
ANAESTHESIA(hrs) ANALGESIA(hrs)
Mepivacaine 
1.5% 
10-15 2.0-2.5 3.0-6.0 
Lidocaine 2% 10-15 2.0-3.0 3.0-6.0 
Ropivacaine 
0.5% 
10-20 3.0-4.0 4.0-10.0 
Bupivacaine 
0.25% 
10-20 3.0-4.0 4.0-10.0 
 
After 10–15 minutes of blockade, there will be decreased 
sensation around the area of nerve distribution. 
 
 
14 
 
Indications for cervical plexus blocks:- 
• Superficial neck surgeries. 
• Carotid endarterectomy. 
• Thyroidectomy and Para-thyroidectomy. 
• Lymph node dissection and plastic repair of neck. 
• Shoulder surgery (supplemental brachial plexus block). 
• Tracheostomy. 
• Central venous cannulation via internal jugular or subclavian 
routes. 
• Cervicogenic headaches. 
• Injuries to the ear, neck and clavicular region including clavicular 
fractures and acromio-clavicular dislocations. 
• Complex regional pain syndrome. 
• Post-herpetic neuralgia. 
• Postoperative pain. 
 
Carotid endarterectomy still remains the commonest indication 
for cervical plexus blocks, usually unilateral combined superficial and 
deep cervical plexus block. 
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Contraindications:- 
• Hemorrhagic diathesis 
• Local neural injury 
• Respiratory compromise 
• Anti-coagulation treatment  
• Anatomic distortion (due to previous surgery or trauma) 
 
Complications:- 
1. Hematoma- 
 Accidental carotid or vertebral artery puncture mainly in 
anticoagulated patients leads to hematoma. Keep at least five minutes 
steady pressure on the site when the artery is punctured inadvertently 
2. Infection- 
             Strict aseptic technique is to be employed for its prevention. 
3. Blockade of phrenic nerve-  
            Phrenic nerve blockade leads to diaphragmatic paralysis. It 
occurs mainly with deep cervical plexus block, so bilateral deep cervical 
plexus block is contraindicated. But it is very rare with superficial 
cervical plexus block. 
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4. Spinal or Epidural anaesthesia – 
 Negative aspiration test is must before injecting the drug. Drug 
should not be injected under pressure and it is better to avoid large 
volume of drug. It can occur with deep cervical plexus block but rare 
with superficial cervical plexus block. 
 
5. Nerve injury – 
 It is due to direct needle injury. So when resistance to injection or 
severe pain is felt stop injecting the drug. 
 
6. Local anesthetic drug toxicity – 
 Most commonly used drugs include Bupivacaine or Ropivacaine. 
It is mainly due to inadvertent intravascular injection and very rarely 
due to absorption. Is more common in this procedure because of high 
vascularity due to vertebral and carotid vessels.So careful aspiration is 
must while injecting the drug. CNS toxicity is more common. 
Accidental intravascular injection into vertebral artery is common 
with deep cervical block, so constant verbal contact with the patient is 
must while injecting the drug. 
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7. Occurs rarely – 
• Horner’s syndrome due to sympathetic chain blockade, 
• Hoarseness, dysphagia due to recurrent laryngeal nerve 
blockade, 
• Upper limb anesthesia due to partial blockade of brachial 
plexus blockade.  
Serious complications like phrenic nerve palsy, vertebral artery 
injection, subarachnoid injection are more common with deep cervical 
plexus block so performing this block bilaterally is contraindicated but 
superficial cervical plexus block which is associated with minimal 
complications can be performed bilaterally without any major concern. 
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APPLIED PHARMACOLOGY 
PHARMACOLOGY OF BUPIVACAINE HYDROCHLORIDE 
 
Bupivacaine was synthesized in Sweden by Ekenstam and his 
colleagues in 1957. It was introduced into clinical practice by L J 
Telivuo in 1963. 
 
 
Chemically it is 1 – butyl - N –  2,6 – dimethyl phenyl , piperdine -2- 
carboxamide. 
 
The structure is similar to Mepivacaine, with a butyl group 
replacing a methyl group in the Piperidine ring. This increases lipid 
solubility and protein binding. High potency is associated with high 
lipid solubility. 
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PHYSIO CHEMICAL PROPERTIES: 
Molecular Weight                       : 288 (base) 
pka at 25ºC                                   : 8.1 
Percentage of protein binding   : 95.6% 
Plasma protein binding              : 2 μgm/ml 
Partition coefficient                   : 27.5 (n-Haptane pH-7.4 buffer) 
Approx. anaesthetic duration   : 175mts. 
Site of metabolism                     : liver 
Safe dosage                                 : 150mg or 2 mg/kg 
Toxic                                      : 4-6 times more toxic than Lignocaine. 
Bupivacaine is manufactured in concentration of 0.25% and 
0.5%. Autonomic blockade is produced by 0.125% solution and this has 
been reported to relieve the pain of labour. Sensory blockade is 
produced with very minimal motor blockade by 0.25% solution. Motor 
blockade is provided by 0.5% solution. 
 Bupivacaine has a much more pronounced effect upon sensory 
nerves than motor nerves, and intense anaesthesia may often be 
obtained without any motor blockade. This is a special advantage in the 
treatment of pain such as post-operative, post traumatic and labour pain. 
Duration of analgesia is between 5 and 16 hours and is the 
longest of any local anaesthetics known. It may be related to its 
increased  protein binding. Commercially it is available as 
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hydrochloride salt. Carbonated Bupivacaine is also available and is said 
to act intensely and widespread. Development of tachyphylaxis is much 
less common than with Lignocaine. 
Action on the cardio vascular system:- 
Bupivacaine is relatively more cardiotoxic than Lignocaine. It is 
powerful myocardial depressant and this is made worse by hypoxia, 
hypercarbia and by pregnancy.  
Ventricular arrhythmias including ventricular fibrillation are 
more lethal nature of Bupivacaine toxicity, probably due to its high lipid 
solubility which causes it to bind firmly to the myocardium there by 
reducing cardiac efficiency. 
According to Moore et al(1979), an arterial plasma concentration 
of 5.4 μgm/ml following an intravenous bolus of Bupivacaine resulted 
in convulsions. The arterial plasma level of Bupivacaine must be more 
than 4μgm/ml before convulsions appear. 
Safety dosage: (2.0mg/kg or 150mg) 
The blood concentration  associated with maximum effective 
dose (cmax ) is 0.7μgm/ml (i.e., with 150mg of 0.5-0.75% Bupivacaine).  
The blood concentration associated with early signs of toxicity 
(ctox) with the same dose of drug is 1.6μgm/ml. The toxicity ratio of 
Bupivacaine is (ctox  / cmax) 2.3 (Tucker et al). However recent studies 
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indicate that higher doses of Bupivacaine 3mg/kg may be used provided 
direct vascular injection is carefully avoided. 
METABOLISM 
Breakdown of bupivacaine is similar to that of mepivacaine and 
commences with removal of the piperidine side chain. The product 
Pipecolyxylidine (PPX) is approximately one-eighth as toxic as 
bupivacaine. PPX and unchanged bupivacaine are slowly excreted in 
about equal proportions in the urine.  
Reynolds (1971), Boyes (1975) reviewed the metabolism of 
Bupivacaine. Hydroxylation of the aromatic ring is believed totake 
place in case of Bupivacaine as with Lignocaine to produce a compound 
that can be conjugated and made water soluble.  
Rothenstein (1983) demonstrated that the human lungs extracted 
local anaesthetic from circulation and subsequently released it back into 
circulation. It is seen with Bupivacaine also. For Bupivacaine the first 
pass pulmonary extraction is dose dependent suggesting that uptake 
process become saturated rapidly (Rothenstein 1984). 
Propranolol impairs Bupivacaine extraction by lungs, perhaps 
reflecting a common receptor site for the two drugs. The conjugated 
water soluble metabolite N-desbutyl bupivacaine is extracted in urine 
and it is less than 40 % of the total local anaesthetic dose. 
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MECHANISM OF ACTION OF LOCAL ANAESTHETICS : 
The sequence whereby clinically used local anaesthetics produce 
inhibition of axonal conduction has been summarized by Corvino as 
follows. 
Clinically all the local anaesthetics exist in solution in both 
charged and uncharged forms, the relative proportions depending on the 
pH of the solution, the pH at the site of injection and pKa of each drug. 
The cation is responsible for most of the nerve blocking effect. 
The clinically used local anaesthetics act primarily on specific 
receptors which are present in the inner aspect of sodium channel. 
 Other possible sites of action include, 
A) Non-specific absorption within the cell membrane lipids 
resulting in membrane expansion and channel narrowing. 
B) Diffusion of the unchanged base via hydrophobic pathways 
through the membrane lipids to reach the specific receptor site, where 
protonation and binding occur in the internal aspect of sodium channel. 
The surface charge theory: The mechanism assumes penetration 
of the axonal membrane by the lipophilic portion of the anaesthetic 
molecules and neutralization of axolemmal surface negative charges by 
the positively charged terminal amino group of the molecule.  
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An accumulation of sufficient positive charges would tend to 
neutralize the relatively electronegativity of the external membrane 
surface resulting in an increase in the trans membrane potential without 
altering the intracellular resting potential. 
 A sufficient increase in the trans membrane potential would 
inhibit the ability of an electric current from a nearby unanaesthetised 
portion of the nerve membrane to depolarize the treated area to its 
threshold for firing. Conduction blockade would then result. 
The surface charge theory requires that the charged form of local 
anaesthetic be the active form. 
 
Therapeutic Uses: 
• Spinal  anaesthesia 
• Epidural anaesthesia 
• Peripheral nerve blocks  
• Infiltration analgesia 
 
Toxicity 
1.Cardiovascular System:More cardio toxic than equieffective 
dose of lidocaine. Manifested clinically as ventricular and myocardial 
depression after inadvertent intravascular administration of 
Bupivacaine. 
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Mechanism of toxicity 
Although both lignocaine and Bupivacaine block cardiac sodium 
channels during systole, Bupivacaine dissociates more slowly than 
lignocaine and therefore significant fraction of sodium channels remain 
blocked during diastole. Thus the block is cumulative and substantially 
more than that is predicted by its local anaesthetic potency. A 
percentage of its cardiac toxicity is centrally mediated. Toxicity is 
enhanced by acidosis, hypoxemia, and hypercarbia. (Levobupivacaine 
the s - enantiomer of bupivacaine is also available with less cardio 
toxicity) 
2. Allergic reactions: Due to the methyl paraben or similar 
preservatives that are structurally similar to para aminobenzoic acid and 
allergic reactions are due to antibody stimulation by the preservative. 
3. Central nervous system: initially there is blockade of 
amygdaloid complex followed by blockade of inhibitory pathways in 
cerebral cortex. Further increase in dose suppresses facilitatory 
pathways leading to central nervous system depression and respiratory 
arrest.Symptoms include light headedness, dizziness, circumoral and 
tongue numbness,visual and auditory disturbances,shivering,twitching 
over distal extremities and face, tonic clonic convulsions,coma and 
respiratory arrest. Seizures are produced by selective inhibition of the 
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inhibitory neurons of Central nervous system leaving unopposed 
excitatory neuron activity. 
 Contraindications: 
1) Hypersensitivity 
2) Should not be used with vasoconstrictor in digits of hand, feet and 
Penis 
3) Stokes Adams syndrome, severe degree of heart block. 
 
Management of Toxicity: 
Cardiac arrest due to local anaesthetic toxicity is very difficult to 
revive. Massive doses of adrenaline and atropine are required. 
Phenytoin and Bretylium can also be used. 
For central nervous system toxicity management is mainly 
supportive. Endotracheal intubation and mechanical ventilation to 
prevent aspiration, hypoxemia and hypercarbia. Thiopentone sodium 
and Benzodiazepines are used to control convulsions.  
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PHARMACOLOGY OF MORPHINE SULPHATE 
 
Morphine is a naturally occurring opioid derived from poppy 
plant. It is a morphinan or Thebaine derivative and it’s a pure agonist. 
 
Chemically it is 5α,6α-7,8 – didehydro-4,5-epoxy-17 – methyl 
morphinan -3,6- diol. 
Morphine is a: 
• Prototype opioid  
• From which other opioid drugs compared.  
MECHANISM OF ACTION: 
Act through opioid µ receptors present in central nervous system. 
Ionized state of opioid is required for strong binding with anionic opioid 
receptor site. Levo rotatory forms are most active. Analgesic potency 
depends on affinity of drug to opioid receptor.   
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1. Binding of drugs leads to decrease activity of adenyl cyclase 
activity which leads to hyperpolarization of the neurons and suppression 
of pain response impulse.    
2. Inhibit release of neurotransmitters like Acetylcholine, 
Dopamine, Nor-epinephrine, substance P which leads to suppression of 
impulse conduction. 
3. Depression of cholinergic transmission.  
Does not alter responsiveness of afferent nerve ending to noxious 
stimulation. Does not impair nerve conduction in peripheral nerve. 
Medical uses:  
• Anaesthesia and Analgesia.  
• Acute and chronic severe pain. 
• Myocardial infarction. 
• Acute pulmonary edema. 
Duration of analgesia: 
 3–4 hours   - Intravenous, 
                    - Subcutaneous, 
                    - Intramuscular route. 
 3–6 hours   - Oral route. 
Routes of administration: Intravenous, intramuscular, subcutaneous, 
oral, rectal, inhalation, insufflations, intrathecal, epidural. 
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Pharmacokinetics:  
• Low lipid solubility. 
• Biotransformation in liver into active metabolite – morphine 6 
glucuronide. 
• Slow onset and prolonged duration of action. 
• Only 10 -20 % drug remains unionized due to high pKa 8. 
• 20 – 40 % protein binding mainly to albumin. 
• 90 % hepatic metabolism. 
• Half-life of 2 – 3 hours. 
• Excretion mainly through renal route and 10% of biliary route. 
• Undergoes extensive first pass metabolism so oral bio-availability 
is only 20-40% but 100% via parental route. 
Metabolites: 80% morphine 3 glucoronide, 10% Morphine 6 
glucoronide and 5% Nor morphine.  
Morphine 6 glucoronide is active one → can cause Analgesia 
and late respiratory depression.It is more potent µ receptor agonist than 
morphine. 
Morphine 3 glucuronide doesn’t bind with opioid receptor. 
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Elimination delayed in: 
1) Renal Failure 
 2) MAO Inhibitors 
3) Elderly 
 4) Neonates  
PHARMACO DYNAMICS:  
Cardiovascular System:  
• Not  a direct myocardial depressant  
• Bradycardia  → increases vagal tone , depresses  Sino atrial node  
• Hypotension due to histamine release and decrease in 
sympathetic discharge . It is severe when, 
– Given along with Inhalational anaesthetics & 
benzodiazepines 
– In dehydrated patient  
– Position other than supine  
Respiratory System: 
• Dose dependent respiratory depression  
• Depress respiratory centre  
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• Reduce the carbon dioxide  responsiveness  
• Reduce rate of respiration  
• Bronchoconstriction → Direct histamine release  
Central Nervous System: 
• Analgesia  
• Sedation  
• Euphoria  
• Doesn’t produce unconsciousness   
• Skeletal muscle rigidity  
• Miosis.  
Biliary System:  Biliary colic  
Gastrointestinal Tract: 
1) Contraction of all sphincters. Reduces Intestinal motility and leads to   
constipation. 
2) Nausea & Vomiting: due to 
– Direct stimulation of chemo receptor trigger zone (CTZ) 
– Diminished  peristalsis  
– More with intramuscular route than intravenous route   
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Placenta: 
• Easily crosses placental barrier. 
• Produce more neonatal depression than pethidine. 
Dose: 
• 0.1mg/kg for premedication  
• 0.2mg/kg for IV administration  
• 1-3 mg → Epidural  
• 100 – 300 цg → Spinal 
• Tolerance    → 2-3 weeks of usage  
• Dependence → 3-4 weeks of usage  
Withdrawal syndrome → occur in 15-20 hrs,takes 10-14 days    to clear.  
Over Dosage: TRIAD →Coma, Miosis,Hypoventilation  
Naloxone is used for reversal of respiratory depression caused by opioid 
overdose as well as treatment of opioid poisoning. 
Renarcotization – reappearance of respiratory depression can 
occur even after Naloxone reversal due to its short half-life (30 – 
60minutes)  
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PHARMACOLOGY OF FENTANYL CITRATE 
Paul Janssen first synthesized fentanyl in the year 1960. 
• Synthetic opioid agonist. 
• Phenyl piperidine derivatives. 
 
 
Chemically it  is N -1-2- phenylethyl-4- piperidinyl-N-phenyl 
propanamide 
Fentanyl as an analgesic is more potent than morphine (75 – 125 
times more potent). 
Fentanyl analogues include sufentanil, alfentanil, remifentanil, 
and lofentanil. 
 
33 
 
Uses: 
- Anesthesia and Analgesia in operation theatre and 
intensive care unit.  
- Sedation for endoscopy and cardiac catheterization. 
- Treatment of chronic pain like cancer pain. 
- Intrathecal and epidural analgesia.  
Pharmacokinetics: 
• Intravenous dose → onset 30 seconds 
• Shorter duration of action  
• Long elimination half time  
• All are because of greater lipid solubility and redistribution in to 
fat tissue  
• 80 % plasma protein binding mainly with α1 acid glycoprotein 
• <10 % unionized fraction  when pKa is 8.4 
• Extensive pulmonary uptake 
• Extensively metabolized in liver  
• Small dose – termination of action depends on redistribution 
• Large dose – termination of action depends on clearance via liver 
• Metabolites are inactive  
• Excreted in bile & urine    
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• Elimination half time 185 – 219 min greater than morphine 
• Further increased in elderly patients, abdominal aortic surgery 
patients. 
Dose:   Wide range of doses 
• 1-2 µg/kg   → Analgesia  
• 2-10µg/kg   → Attenuate stress response   
• 50-150 µg/ kg  → Sole anesthetic   
• oral trans-mucosal route - Lollipop 2-20µg/kg, 
• Transdermal patch - 75-100µg/h Postoperative analgesia for 24 
hrs. 
• Intrathecal ( 10 - 30µg) 
• Epidural  ( 50 - 100 µg) 
Problems: 
• Persistent (or) Recurrent ventilatory depression -due to 
mobilization of opioid from its peripheral storage sites into 
central compartment  
• Bradycardia more than morphine. 
• Skeletal muscle rigidity and myoclonus in large doses. 
                  
 
35 
 
              REVIEW OF LITERATURE 
 
1. Alexandria Journal of Anaesthesia and Intensive Care Vol. (8) 
No. 4 December 2005, Hisham Negmi MD et al 
They studied the effect of bilateral superficial plexus block done 
priorto surgery in reducing the post thyroidectomy pain.Totally fifty 
patients between the age group of 20 – 40years, they were divided into 
two groups. Bilateral superficial plexus block  was done in Group C 
(Control group) with 20 mL of isotonic Normal  Saline solution and 
Group B (Bupivacaine group) with 20 mL bupivacaine 0.25% 
performed before induction of general anesthesia.  After surgery, 
patients were transferred to the PACU where they stayed  for 2 hours, 
then were transferred to the post-operative ward. Patients were followed 
up for 24 hours post operatively. Postoperative pain, Patients’ 
satisfaction, total amount of morphine consumption in the recovery 
room and within 24 hours post operatively was also recorded. The 
Bupivacaine group had decreased requirement of morphine in the 
recovery room and 24 hours after surgery. Patients who were given 
bilateral superficial plexus block had lower VAS scores compared to the 
Group C (Control group).  
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They concluded that bilateral superficial cervical plexus block 
with  Bupivacaine decreases the intensity of  post-operative pain  after 
thyroid surgery and also decreases the post-operative opioid 
requirements. 
2. British Journal of Anaesthesia- 99 (4): 561–6 (2007) G. Andrieu 
et al.  
They conducted the study to assess the analgesic efficacy of 
bilateral superficial cervical plexus block performed just after induction 
of general anaesthesia in subjects undergoing thyroidectomy 
procedures. They were allocated into 3 groups. Group P (Normal 
saline), Group R (Ropivacaine 0.5%) and Group RC (Ropivacaine 0.5% 
and clonidine 5µg/ml). Clonidine gets systemically absorbed and acts 
on the local nerve fibres to prolong the duration of analgesia. Inj. 
Sufentanil i.v was given intraoperatively when there was 20% increase 
in mean arterial pressure or heart rate .The pain score was checked 
every 4th hourly post operatively and Inj. Nefopam i.v was given if 
numerical pain score was more than 4.  
They concluded that bilateral superficial cervical plexus block 
with ropivacaine and clonidine produces better intraoperative analgesia 
when compared to ropivacaine alone. It also decreases the intraoperative 
sufentanil requirement and decreases the analgesic requirements after 
thyroid surgery. 
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3. Alexandria Journal of Anaesthesia and Intensive Care Vol. (9) 
No. 2 June 2006;Ashraf A Moussa, Saudi Arabia 
They assessed the analgesic efficacy of Bilateral superficial 
cervical plexus block in the immediate post-operative period  after 
thyroid surgery alone and when combined with bilateral deep cervical 
plexus block. The patients were divided into 3 groups, with 12 patients 
in each Group. Group A received bilateral superficial plexus block 
before surgery with 10 ml of bupivacaine 0.5%. Group B received as in 
group A  along with Bilateral deep cervical plexus block with 5 ml 
bupivacaine 0.5 %. Group C (Control group) received general 
anaesthesia for thyroid surgery without any block. With the help of 
Numeric rating scale (0-10), pain score was assessed during the post-
operative period. The main variables that had to be compared were the 
proportion of patients who were given morphine during the 24 hours 
postoperatively, numerical rating pain scores and total morphine 
consumption. Groups A & B had lower pain scores and decreased 
requirement of morphine when compared to group C. 
 It was concluded that Bilateral deep cervical plexus block neither 
decreases  the post-operative analgesic requirement  nor decreases the 
intraoperative opioid  requirements when combined with bilateral 
superficial cervical plexus block for pain control after thyroid surgery so 
superficial cervical plexus block is enough for pain relief. 
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4. Anesthesia Analgesia 2001; 92:1538–42. Dieudonne et al 
Superficial cervical blocks after thyroidectomy surgeries. 
 They had done a study to assess the efficacy of bilateral 
Superficial cervical plexus block performed at the end of surgery in 
reducing the post-operative pain. 90 patients who were to undergo 
elective thyroid surgery under general anesthesia were randomized to 
receive 20 mL of isotonic Normal saline or 20 mL of Bupivacaine 
0.25% with 1:200,000 adrenaline tartrate. Postoperative pain was 
assessed every 4th hourly by numeric rating scale. Inj. Acetaminophen 
was given i.v every 6th  hourly. Morphine was administered to the 
patient if NRS-11 score was >4. The variables were pain scores (NRS-
11), the proportion of patients who received morphine at any time 
during the 24-hr period, and the total amount of morphine consumption 
in the 24 hr period. The Bupivacaine group had fewer patients requiring 
morphineand also had lower numerical rating pain scores. 
They concluded that bilateral superficial cervical plexus blocks 
decreases the intensity of post-operative pain after thyroid surgery but  
it does not provide adequate pain relief when done  alone. 
5. World Journal of Surgery (2010) 34:2338–2343 
Ming-Lang et al had conducted a study to evaluate the analgesic 
efficacy of pre operative bilateral superficial cervical plexus block in 
patients undergoing thyroidectomy. 162 patients who underwent  
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elective thyroid operations and were randomly divided into 3 groups. 
Group A received a bilateral superficial cervical block (12 ml per side) 
with isotonic Normal saline, Group B received 12ml of Bupivacaine 
0.5% on each side and Group C received 12ml of Levobupivacaine 
0.5% on each side after induction of general anesthesia. The inhalational 
anesthetic used was desflurane. Post-operative pain was assessed by 
Visual analogue scale. The number of patients who required additional 
postoperative analgesia, the time to the first analgesic requirement, and 
the pain intensity assessed by visual analogue scale (VAS).  Nausea and 
vomiting is one of the common adverse effects seen within 24 hrs after 
thyroid surgeries. It was also noted. They had also compared the 
duration of hospital stay, duration of surgery, if there is any difficulty 
while swallowing and change in voice between the 3 groups.  
They arrived at a conclusion that  bilateral superficial cervical 
plexus block  decreases the  intraoperative inhalational anesthetics 
requirement during thyroid surgery and intensity of postoperative pain 
score and also shortens the duration of stay at the hospital. 
6. Brazilian Journal of Otorhinolaryngology 74 (1) 
January/February 2008,Rui Celso Martins et al  
This study was conducted after obtaining ethical committee 
clearance. It was done to compare the surgeries done under general  
anaesthesia and under superficial cervical plexus block. Patients who 
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were to undergo hemithyroidectomy were divided into 2 groups 21 
patients in each. Group A received general anaesthesia. Standard 
general anaesthesia protocol was followed. Group B received 
Superficial cervical plexus block. Sedation was used prior to the block. 
Inj.Metaprolol was used to decrease the fluctuations in blood pressure 
and heart rate intraoperatively. SBP, DBP, SPO2, HR, ETCO2 were 
monitored. The duration of surgery time was prolonged in Group A 
when compared to group B .There was increased incidence of 
bradycardia in group A. The duration of anaesthesia, time in surgery 
room, treatment costs, and laryngotracheal injury were significantly 
higher in the general anaesthesia group. 
They concluded that Superficial cervical plexus block was 
effective for the resection of small tumors, at a lower cost and with low 
incidence of laryngotracheal injuries, when compared to patients 
undergoing general anaesthesia . 
7. Local and Regional Anesthesia 2012, Sandip Mukhopadhyay et al 
They conducted study to evaluate the effectiveness of Bilateral 
superficial cervical plexus block as a sole anaesthetic technique for 
surgeries in the anterior and anterolateral aspects of the neck. This study  
was conducted on 136 patients who were to undergo neck surgeries. 
Sedation was given prior to the block.  All patients were administered 
bilateral superficial cervical plexus block with ropivacaine 
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hydrochloride 0.5% with 6-7ml on each side. If patient complained of 
pain during the procedure, Inj. ketamine 25 mg intravenously was given 
in intermittent doses. The bilateral cervical plexus block as a sole 
method of anesthesia for surgeries in the anterior and anterolateral 
aspect of neck with ketamine supplementation in titrated doses seems to 
be the ideal alternative to general anaesthesia.  
They concluded that Bilateral cervical plexus block  with 
ketamine supplementation was more cost effective when compared to 
general anaesthesia with lower  incidence of complications.  
8. Anesthesiology 2006; 105: A888, Gilles Lebuffe et al, France 
It was done to evaluate the analgesic efficacy of Bilateral 
Superficial Cervical Plexus Block   performed under general anaesthesia 
in patients who were posted for elective total thyroidectomy. 87 patients 
were randomized into 3 groups. Group T was to  receive  BSCPB with 
saline, Group R was to receive ropivacaine 0.5 % and Group RC was to 
receive  Ropivacaine 0.5% plus clonidine 5µg/ml .Opioid requirement , 
postoperative rescue analgesic requirement was reduced in ropivacaine 
group. On admission in the PACU, lower visual analogue pain scores 
were observed in groups R and RC . 
It was concluded that Bilateral superficial plexus block done with 
ropivacaine and clonidine was more effective anaesthetic technique to 
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reduce the post thyroidectomy pain. Clonidine improves the intra 
operative analgesia. 
 
9. British Journal of Surgery ,Volume 97, Issue 7, pages 1000–
1006, July 2010; T. Steffenet al 
In this study, patients were allocated into 2 groups .Group A 
received bilateral superficial plexus block with placebo and Group B 
received bilateral cervical plexus block group with Bupivacaine at the 
beginning or after the surgery was completed. On the whole, 159  
patients were included. The bupivacaine group had significantly lower 
visual analogue pain scores compared to   the placebo group (P = 
0·016).Length of hospital stay and number of attempts of rescue 
analgesics were similar in both groups. 
They came to the conclusion that bilateral superficial cervical 
block with bupivacaine performed under general anaesthesia 
decreasesthe postoperative pain after thyroid surgeries. 
10.European journal of anaesthesiology, 2009 Dec; 26(12):1043-7 
,Young-Jin et al 
They evaluated the effectiveness of bilateral superficial cervical 
plexus block vs. combined superficial and deep cervical plexus block 
for pain in the line of incision, headache andpain in the posterior aspect 
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of neck after thyroidectomy procedure. Ninety patients were enrolled 
into the study.They were divided into 3 groups of 30 each- Group C was 
the control group, Group S- received bilateral superficial cervical plexus 
and Group DS received bilateral combined superficial and deep cervical 
plexus block group.The block was done under general anaesthesia. 
Remifentanil was the opioid used intraoperatively.HR, SBP, DBP, 
SPO2, ETCO2 were being monitored. 
It was found that the remifentanyl requirement was lower in 
group S when compared to group C and group DS. In the immediate 
post-operative period, the opioid and analgesic requirements were 
significantly reduced in group S (P < 0.001).Pain in the posterior aspect 
of the neck were similar in all the groups. Time of first rescue analgesic 
was significantly prolonged in group S.  
It was concluded that Bilateral Superficial cervical plexus block 
is superior to combined superficial and deep cervical plexus block in 
reducing pain after thyroidectomy procedure. 
11. M.Messner et al conducted a study in which 46 patients who were 
to undergo elective unilateral carotid endarterectomy under general 
anesthesia were divided into 2 Groups of 30 patients each. Group R 
received unilateral Superficial cervical block with ropivacaine 0.5% and   
Group P received the superficial cervical plexus block with the placebo 
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drug. Post-operative pain was assessed by Visual analogue pain scale. 
Morphine was administered via patient controlled analgesia device 
when visual analogue pain score >4.  
The Ropivacaine group had a significant reduction in total 
morphine consumption during the stay in the recovery room ( p < 0.05), 
decreased maximal pain scores, p < 0.001. Patient satisfaction was 
found to be better in the Ropivacaine group (p < 0.001).  
They came to a conclusion that superficial cervical plexus block 
combined with general anaesthesia provides better post-operative  
analgesia in  patients who underwent carotid endarterectomy 
surgery.(European journal of vascular and endovascular surgery 
,vol 33 , Jan 2007 ) 
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MATERIALS AND METHODS 
This was a prospective randomized controlled study. After ethical 
committee approval and informed consent, the study was conducted in 
60 eligible patients after explaining the procedure details to the patients 
the anaesthetic technique was performed. This study was conducted at 
Government Rajaji Hospital attached to Madurai medical college. 
Selection of patients  
INCLUSION CRITERIA:  
• Age group 18 - 60 years, 
• ASA I-III ,  
• Euthyroid patients ,  
• Scheduled to undergo thyroidectomy without 
neck dissection under general balanced 
anesthesia. 
EXCLUSION CRITERIA: 
• Clinical history or laboratory tests suggestive 
of bleeding  disorder    
• Mental or cognitive deficit in existence, which 
makes it impossible to understand the patient 
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visual analogue scale of pain or the study 
protocol 
• Body mass index greater than 35 
• History of allergy to local anesthetics 
• Skin infection at the site of the procedure 
• Patients requiring neck dissection 
• Patients with sub sternal goitre 
• Pregnancy 
• Preoperative use of opioid analgesics or non-
opioids, corticosteroids or non-steroidal anti-
inflammatory drugs 
• Need for emergency reintervention within the 
first 24 hours postoperatively.      
Preoperative preparation  
Preoperative assessment of the patients included, history 
regarding the symptoms and their severity, other associated systemic 
illness, and history of previous surgery. A systematic examination of the 
cardiovascular and respiratory system was done. The neck of the patient 
was examined for adequate flexion and extension and assessment of the 
airway was done. Apart from the basic preoperative investigations like 
blood hemoglobin, sugar, urea, creatinine, specific investigations like 
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serum electrolytes, chest X-ray, X-ray Neck AP and Lateral view to rule 
out tracheal compression, electrocardiogram, and echocardiography 
were done.  
Thyroid function test was done for all patients and euthyroid 
status was assessed. Endocrinologist opinion was obtained for all 
patients. ENT surgeon opinion regarding vocal cords movements was 
also taken. 
 On the day of surgery patients were given their regular 
thyroid/antithyroid drugs orally with sips of water in the morning. The 
patients were premedicated with Glycopyrrolate 4µg/kg and Midazolam 
0.05mg/kg intramuscularly thirty minutes prior to anaesthesia. 
Two groups: 
STUDY GROUP: Bilateral Superficial Cervical Plexus Block with 
BUPIVACAINE 0.25% 10ml on each side. 
CONTROL GROUP: Bilateral Superficial Cervical Plexus Block with 
NORMAL SALINE 10 ml on each side. 
 
Procedure details  
After arrival into the operation theatre pre induction monitors like 
noninvasive blood pressure monitor, electrocardiography, pulse 
oximetry (multiparameter monitor was used) were connected and the 
baseline readings were noted down. 
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 Intravenous cannula was secured in left hand. Block was 
performed 20 minutes prior to induction using Landmark 
technique. 
Patient positioning– Patient put on supine posture with head 
turned to opposite side. Neck and upper chest was exposed to assess the 
relative length and position of sternocleidomastoid muscle. Under strict 
aseptic precautions parts painted and draped. After identifying the 
midpoint of posterior border of sternocleidomastoid muscle, local 
infiltration is given to entry point then ten ml of solution (either 
Bupivacaine 0.25% or Normal Saline)   given subcutaneously in a fan 
shaped manner along the posterior border of sternocleidomastoid.6 ml 
in up and down direction and 4ml just above the muscle horizontally to 
block all the 4 terminal branches .The same thing  performed on other 
side also. So totally 20 ml of 0.25% bupivacaine or 20 ml of normal 
saline was used. After waiting for onset time of around 10 – 15 minutes 
the blockade was assessed by pin prick by a separate assistant. 
All patients were preoxygenated with 100% oxygen for 3 minutes 
and induced with fentanyl citrate 2 µg/kg IV and propofol 2 mg/kg IV. 
Lignocaine hydrochloride 1.5mg/kg was given 90 seconds before 
intubation for stress attenuation. Succinylcholine chloride 1.5mg/kg was 
given for endotracheal intubation. 
49 
 
 Intravenous Loading dose of Atracurium besylate 0.5mg/kg was 
given. Dexamethasone 8mg IV was given to all patients. Anaesthesia 
was maintained with nitrous oxide and oxygen in the ratio 66%:33% 
and sevoflurane 2%. Atracurium besylate infusion 0.5mg/kg/hr was 
started. If mean arterial pressure or heart rate rises by more than 20% 
above basal values which was monitored using multiparameter monitor, 
additional Inj. Fentanyl citrate dose of 0.5 µg /kg was given. 
Intraoperative monitoring was done using multipara monitor 
which includes pulse rate, saturation, and Blood pressure including 
MAP, End tidal carbon dioxide which was maintained around 30 – 35 
mmHg and Electrocardiography. Patients were reversed after adequate 
respiratory attempts and extubated.  
After extubation, laryngoscopy was done to evaluate the vocal 
cord movements and then patient was transferred to recovery room or 
post anaesthetic care unit. 
 
In PACU pain was assessed by using visual analogue scale 
score immediately (H0),afterwards three hourly for the next twelve 
hours  (H3,H6,H9,H12) and every six hrs until twenty four hours( 
H18,H24) .Patients stayed for 2 hours in recovery room then shifted to 
Surgical Intensive Care Unit . 
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If VAS ≥ 40mm, Morphine 1 – 2 mg given IV,then patients were 
assessed every 10 minutes until VAS becomes <40mm. 
Post operatively patients were monitored for any episodes of: 
• Bradycardia 
• Hypotension 
• Nausea  
• Vomiting 
• Excessive Sedation  
• Respiratory depression- respiratory rate and oxygen saturation 
was monitored. 
 
 
51 
 
Hypotension : fall of more than 30% from the baseline blood pressure 
or the systolic blood pressure less than 90mmHg, it was treated with 
fluids, vasopressors as necessary. 
Bradycardia:if rate goes below 50/minute atropine was used. 
Sedation: Ramsay sedation score (1 -6) : 
Patient awake:  
• Anxious and Agitated  - 1 
• Oriented and comfortable - 2 
• Follows command only - 3 
Patient sleeping: 
• Response is brisk to glabellar tap/loud auditory stimuli - 4 
• Response is sluggish - 5 
• Response is absent - 6 
 
Any adverse event related to surgery & regional anaesthetic 
technique was also recorded.  
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STATISTICAL TOOLS 
The information collected regarding all the selected cases were 
recorded in a Master Chart. Data analysis was done with the help of 
computer using Epidemiological Information Package (EPI 2010) 
developed by Centre for Disease Control, Atlanta.  
 Using this software range, frequencies, percentages, means, 
standard deviations, chi square and 'p' values were calculated. Two 
types of chi square test were used to calculate the significance. Kruskul 
Wallis test was used for quantitative variables and Yates test for 
qualitative variables. A relationship was significant if p value is less 
than 0.05. 
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OBSERVATIONS AND RESULTS 
STUDY GROUP: Bilateral Superficial Cervical Plexus Block with 
BUPIVACAINE 0.25% 10ml on each side. 
CONTROL GROUP: Bilateral Superficial Cervical Plexus Block with 
NORMAL SALINE 10 ml on each side. 
Complications of the procedure like vascular puncture, 
hematomas, etc. if occurred were noted down. Only successful blocks 
were considered for study group. 
Baseline, intraoperative and postoperative pulse rate, blood 
pressure, oxygen saturation were monitored using multipara monitor. 
In the intra operative period, the total dose of intraoperative 
opioid requirement used was recorded and compared. 
In the postoperative period number of patients having VAS ≥ 40mm 
at H0, morphine requirement in post anaesthetic care unit and in 
surgical intensive care unit and its dosage and total patients requiring 
morphine were recorded and compared 
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CHARACTERISTICS OF CASES STUDIED 
Table 1: Age distribution 
Age group Study group Control 
group 
No % No % 
Less than 30 years 2 6.7 7 23.3 
30-39 years 12 40 10 33.3 
40-49 years 9 30 7 23.3 
50 & above 7 23.3 6 20 
Total 30 100 30 100 
Range 23-55 years 20-60 years 
Mean 39.9 years 37.8 years 
SD 8.7 years 11.3 years 
‘p’ 0.3781 
Not significant 
Study group had an age of 39.9 ± 8.7 years while Control group had 
37.8 ± 11.3 years. The difference was not statistically significant. 
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Table 2: Sex distribution 
 
Sex Study group Control 
group 
No % No % 
Male 4 13.3 5 16.7 
Female 26 86.7 25 83.3 
‘p’ 0.5 
Not significant 
 
Nearly 90% of the patients were female. Sex composition of both the 
groups did not have significant difference. 
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Table 3: Weight 
 
Group Weight in kgs 
Range Mean SD 
Study group 44-64 51.3 4.8 
Control group 44-64 51.5 5.2 
‘p’ 0.9055 
Not significant 
 
Mean weight of the Study Group was 51.3kgs and the Control Group 
was 51.5kgs. Not statistically significant (‘p’ value= 0.9055). 
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Table 4: ASA 
 
ASA Study group Control 
group 
No % No % 
II 29 96.67 29 96.67 
III 1 3.33 1 3.33 
Total 30 100 30 100 
 
96.67% of patients in both groups belong to ASA II. 
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Table 5: Diagnosis 
 
Diagnosis Study group Control 
group 
No % No % 
Ca. Thyroid 1 3.3 1 3.3 
MNG 23 76.7 26 86.7 
MNG (T) 5 16.7 2 6.7 
SNG - - 1 3.3 
SNG R (T) 1 3.3 - - 
In total 30 100 30 100 
 
Most patients were having Multi Nodular Goiter (MNG) and underwent 
subtotal/near-total thyroidectomy. 5 MNG and 1 SNG patients 
underwent (T)total  thyroidectomy. 
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Table 6: Duration of surgery 
 
Group Duration of surgery ( in minutes) 
Range Mean SD 
Study group 85-120 100.3 7.6 
Control group 85-120 101 7.6 
‘p’ 0.7111 
Not significant 
 
Mean duration of surgery in study group was 100.3 minutes and in 
control group was 101 minutes. It was not statistically significant (‘p’ 
value= 0.7111). 
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Table 7: Duration of Anaesthesia 
 
Group Duration of Anaesthesia(in minutes) 
Range Mean SD 
Study group 110-140 121.7 7.1 
Control group 110-140 123.3 7.8 
‘p’ 0.3342 
Not significant 
 
Mean duration of anaesthesia in study group was 121.7 minutes and in 
control group it was around 123.3 minutes which was not statistically 
significant ( p value= 0.3342). 
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Table 8: Base line Hemodynamic variables 
 
Variables Study Group Control 
Group  
‘p’ 
No % No % 
Pulse rate(/minute) 
 
82.0 9.6 81.7 9.4 0.935 
Not significant 
Systolic BP(mmhg) 117.2 13.4 119.2 12.5 0.4552 
Not significant 
Diastolic BP(mmhg) 71.9 8.3 73.0 8.7 0.6481 
Not significant 
SPO2(%) 98.5 0.7 98.5 0.7 0.8418 
Not significant 
 
Base line hemodynamic variables were comparable between the two 
groups with p value being statistically not significant . 
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Table 9: Intra operative Fentanyl Requirement 
 
 
Group 
Intra operative Fentanyl ( in 
micrograms) 
Range Mean SD 
Study group 70-100 79.7 8.7 
Control group 110-170 132.5 14.2 
‘p’ 0.0001 
Significant 
 
Intraoperative fentanyl requirement in study group was 79.7 ± 8.7µg 
and in control group was 132.5 ± 14.2µg which was statistically 
significant (‘p’ value is 0.0001). 
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Table 10: VAS score > 40 mm in PACU ( 0 hour) 
 
 
Group 
VAS > 40 mm in PACU (0 hour) 
Yes No 
No % No % 
Study group 5 16.7 25 83.3 
Control group 21 70 9 30 
‘p’ 0.0001 
Significant 
 
70% patients in control group had VAS score of > 40mm in immediate 
post-operative period compared to 16.7% in study group which was 
very much statistically significant ( p value 0.0001). 
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Table 11: Morphine Requirement. 
 
Group Morphine dose in milligrams 
In PACU In SICU Total dose(upto 
24hours) 
Mean SD Mean SD Mean SD 
Study group 0.83 1.93 1.97 2.37 2.8 3.6 
Control 
group 
6.13 3.59 5.07 1.74 11.2 4.1 
‘p’ 0.0001 
Significant 
0.0001 
Significant 
0.0001 
Significant 
 
 
There was statistically significant difference between the two groups in 
morphine requirements in post anaesthetic care unit, surgical intensive 
care unit and also in 24hour dose requirements. Study group required 
less morphine than control group (p value 0.0001). 
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Table 12: Total number of patients requiring morphine in first 24 
hrs postoperatively 
 
Group 
MORPHINE 
requirement(up to 24 
hours) 
Yes No 
 %  % 
Study group 13 43.3 17 56.7 
Control group 28 93.3 2 6.7 
‘p’ 0.0001 
Significant 
 
93.3% patients in the control group required morphine in the first 24 
hours postoperatively compared 43.3% patients in study group. 
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Table 13: Incidence of post-operative vomiting 
 
 
Group 
Post-operative vomiting 
Yes No 
 %  % 
Study group 5 16.7 25 83.3 
Control group 8 26.7 22 73.3 
‘p’ 0.5308 
Not significant 
 
Even though 26.7% patients in control group had post-operative 
vomiting it was not statistically significant in relation to study group 
(‘p’ value 0.5308). 
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Table 14: Sedation score (Ramsay Sedation Score) 
 
Sedation score 
 
Study group Control 
group 
No % No % 
2 30 100 26 86.7 
3 - - 4 13.3 
‘p’ 0.0562 
Not significant 
 
 
Only13.3% patients in control group had sedation score of 3. Rest of the 
patients had a score 2 in both groups. 
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Table 15: Post operative changes in pulse rate 
 
 
Pulse 
rate/minute 
at 
Study Group  Control Group  
‘p’ 
 
Significance Mean SD Mean SD 
0 minute 83.9 8.0 84.3 9.2 0.8471 Not significant 
30 minutes 86.7 8.5 83.6 9.2 0.1824 Not significant 
1 hour 86.9 8.0 86.0 8.9 0.7612 Not significant 
2 hours 84.7 8.4 86.6 8.3 0.3577 Not significant 
3 hours 87.5 6.8 87.4 8.3 0.8297 Not significant 
6 hours 86.6 8.0 87.3 9.0 0.767 Not significant 
9 hours 87.5 8.5 85.3 8.5 0.2827 Not significant 
6 hours 85.8 8.6 89.7 7.0 0.0696 Not significant 
12 hours 85.6 8.5 86.0 8.9 0.7612 Not significant 
18 hours 82.0 8.8 86.6 8.3 0.3577 Not significant 
24 hours 87.5 8.5 85.3 8.5 0.2827 Not significant 
 
Post operative changes in pulse rate were comparable in both groups.  
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Table 16: Changes in systolic blood pressure 
 
 
 
SBP at 
SBP(mmHg) in  
 
‘p’ 
 
 
Significance 
Study Group  Control Group 
Mean SD Mean SD 
0 minute 112.5 10.2 115.3 9.7 0.2504 Not significant
30 minutes 111.9 9.8 113.8 10.3 0.4495 Not significant
1 hour 112.3 8.9 114.3 8.9 0.342 Not significant
2 hours 110.1 9.4 113.7 9.7 0.1174 Not significant
3 hours 113.3 9.0 114.5 10.1 0.8295 Not significant
6 hours 113.8 8.8 114.7 10.5 0.7215 Not significant
9 hours 113.5 8.7 116.8 8.7 0.1527 Not significant
12 hours 112.7 9.1 114.7 10.5 0.5727 Not significant
18 hours 115.9 9.0 114.3 8.9 0.342 Not significant
24 hours 113.5 8.8 113.7 9.7 0.1174 Not significant
 
There was no statistically significant difference in systolic blood 
pressure changes between the two groups. 
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Table 17: Changes in diastolic blood pressure 
 
 
 
DBP at 
DBP(mmHg) in  
 
‘p’ 
 
 
Significance 
Study Group  Control 
Group  
Mean SD Mean SD 
0 minute 73.8 8.6 70.5 7.0 0.1707 Not significant
30 minutes 75.2 9.0 73.9 8.2 0.5772 Not significant
1 hour 71.1 8.0 72.2 7.4 0.6013 Not significant
2 hours 74.7 8.7 74.3 8.4 0.8817 Not significant
3 hours 72.0 7.0 72.8 8.6 0.9941 Not significant
6 hours 72.7 8.6 72.6 7.9 0.8338 Not significant
9 hours 71.8 6.5 74.9 8.7 0.1733 Not significant
12 hours 75.5 9.7 71.0 7.2 0.083 Not significant
18 hours 74.7 10.8 74.3 8.4 0.8817 Not significant
24 hours 70.6 8.5 72.8 8.6 0.9941 Not significant
 
There was no statistically significant difference in diastolic blood 
pressure changes between the two groups. 
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Table 18: Changes in respiratory rate/ minute 
 
Respiratory 
rate at 
Study Group  Control Group  
‘p’ 
 
Significance Mean SD Mean SD 
0 minute 13.7 0.6 13.8 1.1 0.6221 Not significant 
30 minutes 13.9 1.0 13.7 0.7 0.35 Not significant 
1 hour 13.8 1.1 13.1 1.0 0.0645 Not significant 
2 hours 13.7 1.0 13.8 0.9 0.7432 Not significant 
3 hours 13.7 1.0 13.8 1.0 0.4491 Not significant 
6 hours 13.8 1.1 13.9 0.8 0.8212 Not significant 
9 hours 13.7 0.6 13.8 0.9 0.6148 Not significant 
12 hours 13.9 1.1 13.9 1.1 1.0 Not significant 
18 hours 13.9 1.2 13.1 1.0 0.0645 Not significant 
24 hours 13.7 0.8 13.8 0.9 0.7432 Not significant 
 
There was no statistically significant difference in respiratory rate 
changes between the two groups. 
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Table 19:  Changes in SPO2 
 
 
 
SPO2 at 
SPO2(%) in  
 
‘p’ 
 
 
Significance 
Study Group  Control Group 
Mean SD Mean SD 
0 minute 98.7 0.7 98.7 0.7 0.674 Not significant 
30 minutes 98.7 0.6 98.4 0.6 1.0 Not significant 
1 hour 98.5 0.5 98.8 0.7 0.1353 Not significant 
2 hours 98.7 0.6 98.5 0.6 0.1633 Not significant 
3 hours 98.8 0.7 98.5 0.6 0.1848 Not significant 
6 hours 98.7 0.6 98.6 0.6 0.3527 Not significant 
9 hours 98.5 0.5 98.2 0.6 0.2435 Not significant 
12 hours 98.7 0.6 98.7 0.5 0.1134 Not significant 
18 hours 98.5 0.5 98.8 0.7 0.1353 Not significant 
24 hours 98.7 0.6 98.5 0.6 0.1633 Not significant 
 
There was no statistically significant difference in peripheral oxygen 
saturation changes between the two groups. 
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                                        DISCUSSION 
 Pre emptive analgesia is a modality of analgesia that is provided 
before surgery. It results in interruption of transmission of pain signals 
arising from various noxious stimuli. This interruption of pain signals 
abolishes the sensitization of both central and peripheral pain pathways. 
Recently regional anaesthetic techniques including peripheral 
nerve blocks are commonly used in the management of perioperative 
pain for due to their distinct advantages over general anaesthesia and 
central neuraxial anaesthesia. 
Pain relief with peripheral nerve block is devoid of adverse 
effects like somnolence, hemodynamic instability, nausea, vomiting   
and voiding difficulties inherent to general anaesthesia and central 
neuraxial anaesthesia. 
Other methods to reduce postoperative pain following thyroid 
surgeries include wound infiltration with local anaesthetics, cervical 
plexus block which includes both superficial and deep cervical plexus 
block. 
Among this bilateral superficial cervical plexus block is 
commonly used due to its efficacy and simplicity in performing the 
technique and without much complications.  Deep cervical plexus block 
is an alternative technique but associated with serious complications 
like phrenic nerve palsy. 
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Diedonne et al showed that pain following thyroid surgeries 
includes two components, superficial and deep. But superficial 
component is considered as the major source of post-operative pain. 
This study showed reduced postoperative pain intensity and opioid 
requirement thus proving large superficial component of post 
thyroidectomy pain. 
Ashraf A Moussa et al found out that there was no difference 
between superficial cervical plexus blocks and combined superficial and 
deep cervical plexus block in analgesic requirements. 
 This technique of combining superficial and deep cervical plexus 
block was commonly employed for patients undergoing carotid 
endarterectomy in conditions where general anaesthesia is 
contraindicated. 
Deep cervical plexus block has got its own disadvantage ranging 
from difficulty in performing the block to more serious complications 
like phrenic nerve palsy, most common one .Others include epidural or 
subarachnoid or vertebral artery injection. 
 
In this study following parameters are observed and compared: 
- Total dose of Intraoperative fentanyl requirement 
- Total dose of Postoperative Morphine requirement 
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- Postoperative side effects  
- Complications associated with the procedures 
 
Intra operative and Post-operative Opioid consumption: 
In this study intraoperative fentanyl requirement in study group 
was 79.7 ± 8.7µg and in control group was 132.5 ± 14.2µg which was ( 
p value .0001)statistically significant. 
There was statistically significant difference (p value .0001) 
between the two groups in morphine requirements in post anaesthetic 
care unit, surgical intensive care unit and also in 24hour dose 
requirements. Study group required less morphine than control group. 
Study group had a morphine requirement of 0.83 ± 1.93 mg, 1.97 
± 2.37 mg and 2.8 ± 3.6 mg in post anaesthetic care unit, surgical 
intensive care unit and in the first 24 hour postoperative period 
respectively while control group had 6.13 ± 3.59 mg, 5.07 ± 1.74 mg  
and 11.2 ± 4.1 mg in post anaesthetic care unit,surgical intensive care 
unit and in the first  24 hours postoperative period respectively. 
Overall 93.3% patients required morphine at any time during the 
first 24 hours postoperatively in control group compared to 43.3% 
patients in study group. 
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70% patients in control group had VAS score of > 40mm in 
immediate post-operative period compared to 16.7% in study group. 
Ashraf A Moussa et al (AJAIC 2006) their study showed the 
advantage of giving bilateral superficial cervical plexus blocks 
compared to General Anaesthesia alone without any block had opioid 
sparing effect both intraoperatively and postoperatively and also lower 
Visual Analogue Scale score both in surgical intensive care unit and 
first 24 hour postoperatively. 
Significantly lower intraoperative remifentanil was required in 
blockgroups (39.97% and 41.67% respectively) when compared to 
control group.  50% of patients with superficial cervical plexus blocks 
did not require any analgesic in the post anaesthetic care unit, while 
33.3% of the patients in both groups, did not require morphine during 
the 24 hrs after surgery. The morphine requirements in both active block 
groups was 50% less than the control group in the post anaesthetic care 
unit and around 60%, less in the ward, 24 hours after surgery. In this 
study, deep cervical plexus block did not have any extra opioid sparing 
benefits when compared to patients with bilateral superficial cervical 
plexus block. 
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Diedonne et al, showed performing cervical plexus block 
decreased the analgesic requirement in both immediate and late (first 24 
hours) post-operative period. Only 55% of patients needed opioids in 
the immediate post-operative period and 65% in the first 24 hours post 
operatively. 
Gozal et al conducted a study which showed that thirty percent 
patients only required opioids, when the wound was infiltrated with 10 
ml of 0.5% bupivacaine. 
Hannibal et al showed pre-operative wound infiltration by 
bupivacaine reduced early and late post-operative morphine 
requirement. 
Andrieu et al showed that intraoperative sulfentanil requirements 
were reduced in superficial cervical plexus block groups. Post 
operatively, nefopam requirement was also reduced in cervical plexus 
block group .There were no complications related to superficial cervical 
plexus block.   
Prasad, Shanmugam, Pandit et al described superficial cervical 
plexus block as cost effective, lower risk with fewer complications 
providing good analgesia , adequate patient satisfaction and shortened 
hospital stay. 
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Postoperative side effects: 
Vomiting 
Five patients had vomiting in study group compared to  Eight  
patients in control group inthe post-operative period, even though 
control group had higher incidence it was not statistically significant 
(‘p’ value 0.5308). 
 
Sonner et al, in their study reported high incidence of post-
operative vomiting following thyroidectomy which was around 55%. 
Thyroid surgery has high risk of nausea and vomiting post operatively, 
whichis more common among women and with volatile anaesthetics.  
 
Sedation  
 In study group maximum Ramsay sedation score was Two. Even 
though 13.3% subjects in control group had sedation score of Three, it 
was not statistically significant (‘p’ value 0.0562). 
 
Complications: 
None of the patients in both the groups had vascular puncture, 
local anaesthetic toxicity, phrenic nerve palsy, spinal or epidural 
blockade. 
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As such complications with superficial cervical plexus block are 
very rare and few but when combined with deep cervical plexus block 
complication rate increases and also of more serious nature like phrenic 
nerve palsy etc. 
World Journal of Surgery 2010 ,in this article they have 
mentioned that  one patient had phrenic nerve and brachial plexus 
blockade following superficial cervical plexus block with 0.5% 
Bupivacaine, 12ml on both sides, that resolved after 6 hours .Reason 
noted was the patient was thin and most probably injection was deeper . 
There was no incidence of bradycardia, vascular puncture, 
hypotension, respiratory depression, and fall in oxygen saturation, 
phrenic nerve palsy, epidural or intrathecal injection or local anaesthetic 
toxicity in both the groups. 
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                                           SUMMARY 
The aim of the study was to prospectively evaluate the analgesic 
efficacy of preoperative bilateral superficial cervical plexus block in 
patients undergoing thyroidectomy under general anaesthesia. This 
study included 60 eligible patients who were divided into two groups, 
30 in each. Study Group received bilateral superficial cervical plexus 
block with Bupivacaine 0.25% 10ml on each side ,Control Group 
received bilateral superficial cervical plexus block  with normal saline 
10 ml on each side. Block was performed 20 mins prior to induction 
using landmark technique. After waiting for onset time of around 10 – 
15 minutes the blockade was assessed by pin prick by a separate 
assistant, General Anaesthesia was given to all patients. Anaesthesia 
was standardized for all patients.  
Intraoperative monitoring was done using multipara monitor 
which includes pulse rate, saturation, bloodpressure, end tidal carbon 
dioxide and electrocardiography.If mean arterial pressure or heart rate 
rises by more than 20% above basal values addition fentanyl citrate 
dose of 0.5 µg /kg was given. At end of the surgery residual 
neuromuscular blockade was reversed and patients were extubated. 
After extubation, laryngoscopy was done to evaluate the vocal cord 
movements and then patient transferred to post anaesthetic care unit. 
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In post anaesthetic care unit, post-operative pain assessment was 
done by using visual analogue scale score  (VAS score) when patient 
was able to communicate (H0),then after every 3 hours for the first 12 
hrs (H3,H6,H9,H12) and every 6hrs until 24 hrs( H18,H24) .Patients 
stayed for 2 hours in PACU, then shifted to Surgical Intensive Care Unit 
(SICU).If VAS ≥ 40mm, Morphine 1 – 2 mg given IV,  then patients 
were assessed every 10 minutes until VAS  score becomes <40mm. 
Observations: 
Complications of the procedure like vascular puncture, 
hematomas etc. if occurred were noted down.Only successful blocks 
were considered for study group. Demographic details were comparable 
in both groups. Base line hemodynamic variables were also comparable 
in both groups. In the intraoperative period, the total dose of 
intraoperative opioid used was noted. In the postoperative period 
number of patients having VAS ≥ 40mm at H0, morphine requirement 
in PACU and patients requiring morphine in SICU and its dosage were 
recorded. Post operatively patients were monitored for any episodes of 
bradycardia, hypotension, nausea, vomiting, excessive  sedation and 
respiratory depression - respiratory rate and oxygen saturation was 
monitored. 
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Of the two groups intraoperative fentanyl requirement in study 
group was 79.7 ± 8.7µg and in control group was 132.5 ± 14.2µg which 
was significant (p value = 0.0001). Study group had a morphine  
requirement of 0.83 ± 1.93 mg ,1.97 ± 2.37 mg and 2.8 ± 3.6 mg in post 
anaesthetic care unit , surgical intensive care unit and in the first  24hour 
postoperative period respectively while control group had 6.13 ± 3.59 
mg, 5.07 ± 1.74 mg  and 11.2 ± 4.1 mg in post anaesthetic care unit 
,surgical intensive care unit and in the first  24 hour postoperative 
period respectively which was statistically significant (p value= 
0.0001). 
Overall 93.3% patients in the control group required morphineat 
any time during first 24 hours postoperatively compared 43.3% patients 
in study group which was statistically significant ( p value 0.0001). 
70% patients in control group had VAS score of > 40mm in 
immediate post-operative period (H0) compared to 16.7% in study 
group which was significant statistically (p value 0.0001). 
Five patients in study group and Eight patients in control group 
had post-operative vomiting. Even though control group had higher 
incidence, it was not statistically significant (‘p’ value 0.5308). 
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 In study group, maximum Ramsay sedation score was two. Even 
though 13.3% patients in control group had sedation score of three, it 
was not statistically significant (‘p’ value 0.0562). 
There was no incidence of bradycardia, vascular puncture, 
hypotension, respiratory depression, and fall in oxygen saturation, 
phrenic nerve palsy, epidural or intrathecal injection or local anaesthetic 
toxicity in both the groups. 
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                                            CONCLUSION 
In conclusion, the data and the statistical analysis suggest that 
“Bilateral superficial cervical plexus block”is an effective and safe 
peripheral nerve blockade technique  which reduces opioid requirements 
both intra operatively and post operatively and also reduces pain 
intensity score in post-operative period without any serious 
complications for patients undergoing thyroid surgeries under general 
anaesthesia. 
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         PROFORMA 
EVALUATION OF ANALGESIC EFFICACY OF 
PREOPERATIVE BILATERAL SUPERFICIAL CERVICAL 
PLEXUS BLOCK IN PATIENTS UNDERGOING 
THYROIDECTOMY UNDER GENERAL ANAESTHESIA 
 
Name of the patient:   IPNo:                 Date: 
 
Age / Sex: M / F    Weight:       kgs             Diagnosis: 
 
Surgery:      ASA :I / II / III 
 
Duration of surgery:-        mins   Duration of Anaesthesia:-       mins  
 
INVESTIGATIONS: 
Blood: 
Hb      %     Sugar:     mg%    Urea:    mg%   Creatinine:     mg% 
 
Serum:       Sodium meq/L        Potassium:       meq/L 
ECG: 
ECHO:          
TFT:     T3:        ng/dl      T4:         µg/dl       TSH:            µIU/ml 
Preoperative Vitals: 
Pulse rate:      /min    Blood pressure:       /      mmhg   SPO2:    % 
Premedication:Inj. glycopyrolate 4 µg /kg, midazolam 0.05mg /kg 
 Group:  Study:- BSCPB with bupivacaine 0.25% 
             Control:- BSCPB with normal saline 
Performed bilaterally - 10ml on each side. 
Block performed 20 mins prior to induction. 
Anaesthesia standardized for all patients 
Induction:- Inj.Propofol 2mg/kg, Inj .fentanyl 2 µg /kg, 
Inj.suxamethonium 1.5mg/kg 
Maintenance:- N2O:O2::66:33% , Sevoflurane 2% ,Inj. Atracurium 
infusion 0.5mg/kg/hr 
Reversal : Inj.glycopyrolate  10 µg /kg , Inj.neostigmine 40 µg /kg   
Supplemental  Fentanyl dose  given ( 0.5 µg/kg) – when there is 
increase in mean arterial pressure(MAP) or heart rate(HR) of > 20 % 
from the base line values. 
 
Intraoperative monitoring - done using multiparameter monitor which 
includes pulse rate ,saturation ,blood pressure including mean arterial 
pressure, end tidal carbon dioxide and electrocardiography. 
After extubation:- Vocal cord movements – 
Intraoperative fentanyl dose:   
Postoperative monitoring: 
Post-operative pain assessment using VAS: H0 in PACU when 
patient able to communicate, every 3hrs for the first 12 hrs & every 6hrs 
until 24 hrs.(H0, H3, H6,H9,H12,H18,H24) 
 
 
If VAS ≥ 40mm inj Morphine 1- 2mg given, assessed every 10 mins 
until VAS <40mm 
 H0 H3 H6 H9 H12 H18 H24 
VAS        
Morphine 
requirement 
       
 
Total dose of morphine requirement: 
PACU:         mg       SICU:        mg 
Total dose:          mg 
Side effects: Bradycardia/ Hypotension /Nausea / Vomiting/ 
Sedation/ Respiratory depression 
Respiratory rate:      /min  
Oxygen saturation:       % 
 
Hypotension: fall of more than 30% from the baseline blood pressure 
or the systolic blood pressure less than 90mmHg, it was treated with 
fluids, vasopressors as necessary.  
Bradycardia: Heart rate  less than 50/min and was treated with 
atropine. 
 
 
Sedation: Ramsay sedation score (1 -6): 
Patient awake:  
• Anxious and Agitated  - 1 
• Oriented and comfortable - 2 
• Follows command only - 3 
Patient sleeping: 
• Response is brisk to glabellar tap/loud auditory stimuli - 4 
• Response is sluggish - 5 
• Response is absent– 6 
 
Complications of Block- Hematoma / infection / any other adverse 
events were noted. 
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1 tamilarasi 30 F 45 650 MNG NTT 120 140 110 yes 8 yes 6 14 Y 2
2 mahesmari 26 F 48 533 MNG STT 95 120 125 no 0 yes 8 8 N 2
3 devaki 24 F 50 1278 MNG STT 100 120 130 yes 7 yes 6 13 N 2
4 petchiammal 50 F 44 2253 Cathyr TT 110 135 115 yes 6 yes 5 11 N 2
5 pandiyammal 60 F 48 2953 MNG STT 85 110 130 no 0 no 0 0 N 2
6 ramzan 40 F 52 2494 MNG STT 95 115 130 yes 9 yes 4 13 Y 2
7 jaya 36 F 56 2222 MNG STT 95 110 140 yes 8 yes 6 14 Y 3
8 mookan 41 M 59 3813 MNG STT 105 125 150 no 0 yes 6 6 N 2
9 saraswathy 55 F 54 6046 MNG NTT 90 115 140 yes 6 yes 5 11 N 2
10 kavitha 30 F 48 6414 SNG TT 95 120 110 yes 10 yes 4 14 Y 2
11 jyothi 29 F 48 6503 MNG STT 90 110 120 no 0 yes 6 6 N 2
12 nirmala 30 F 44 5805 MNG TT 95 120 110 yes 9 yes 7 16 Y 3
13 mariammal 37 F 48 9951 MNG TT 100 125 120 no 0 yes 5 5 N 2
14 subashini 23 F 55 7511 MNG STT 110 135 140 yes 8 yes 4 12 N 2
15 veeralakshmi 45 F 58 9497 MNG STT 105 130 145 yes 9 yes 5 14 N 2
16 malliga 34 F 51 3858 MNG STT 100 125 120 no 0 yes 7 7 N 2
17 selvi 33 F 50 9202 MNG TT 95 120 130 yes 7 yes 6 13 N 2
18 kamatchi 32 F 48 11187 MNG STT 100 115 130 yes 8 yes 5 13 N 2
19 amudha 36 F 47 5020 MNG NTT 105 120 130 yes 6 yes 7 13 N 2
20 lakshmi 40 F 46 6433 MNG NTT 110 130 130 yes 10 yes 4 14 Y 3
21 kaleeswari 20 F 54 14365 MNG(T) STT 110 130 140 no 0 no 0 0 N 2
22 raja 46 M 64 12647 MNG STT 105 130 160 yes 8 yes 4 12 N 2
23 muthamal 45 F 52 9961 MNG TT 95 120 130 yes 9 yes 6 15 Y 3
24 devi 56 F 49 14354 MNG(T) STT 100 125 125 yes 7 yes 6 13 Y 2
25 shanthi 46 F 54 18724 MNG STT 105 130 140 no 9 yes 4 13 N 2
26 ramachandran 55 M 49 19382 MNG STT 100 125 130 yes 8 yes 6 14 N 2
27 manimegalli 53 F 51 16152 MNG STT 105 125 130 yes 8 yes 5 13 N 2
28 kavitha 36 F 54 22288 MNG STT 110 130 145 yes 8 yes 5 13 N 2
29 vadivelu 20 M 56 22878 MNG STT 105 130 150 yes 9 yes 4 13 N 2
30 ramesh 27 M 64 22955 MNG STT 95 115 170 no 7 yes 6 13 N 2
CONTROL GROUP - BSCPB WITH NORMAL SALINE
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1 sundari 50 F 56 58733 MNG TT 105 125 80 no 0 no 0 0 N 2
2 nagammal 54 F 48 60435 MNG TT 100 120 70 no 0 no 0 0 N 2
3 chittammal 44 F 55 58801 MNG STT 95 115 90 no 0 yes 5 5 N 2
4 sudha 24 F 53 62326 MNG STT 100 120 90 no 0 no 0 0 N 2
5 alagi 50 F 48 53956 MNG(T) NTT 105 125 80 no 0 no 0 0 N 2
6 seeramal 35 F 48 63584 MNG STT 110 130 80 yes 6 yes 3 9 Y 2
7 selvi 50 F 44 57410 MNG(T) NTT 100 115 70 no 0 no 0 0 N 2
8 vasantha 30 F 51 61552 MNG STT 105 120 80 no 0 yes 6 6 N 2
9 jyothi 55 F 50 6257 MNG STT 95 115 80 no 0 no 0 0 N 2
10 shanthi 40 F 47 57882 MNG STT 100 120 80 no 0 yes 4 4 N 2
11 parameshwari 45 F 53 66619 MNG STT 105 125 90 no 0 no 0 0 N 2
12 nagajyothi 40 F 52 60782 MNG(T) NTT 100 125 100 no 0 yes 5 5 N 2
13 latha 39 F 44 68117 MNG STT 105 130 70 no 0 no 0 0 N 2
14 palaniyammal 38 F 47 69142 MNG STT 110 125 75 yes 6 yes 3 9 Y 2
15 thavamani 30 F 49 69710 MNG NTT 105 130 70 no 0 no 0 0 N 2
16 balaganesh 40 M 60 70539 MNG NTT 95 120 80 no 0 no 0 0 N 2
17 manjammal 42 F 56 71076 MNG STT 90 115 75 no 0 yes 5 5 N 2
18 jemila 23 F 51 73439 MNG STT 95 115 70 no 0 no 0 0 N 2
19 devi 31 F 46 69751 SNG R(T NTT 100 120 75 yes 4 yes 4 8 N 2
20 selvarani 35 F 45 62020 MNG STT 110 130 70 no 0 no 0 0 N 2
21 lathalaxmi 32 F 50 63405 MNG(T) NTT 85 110 80 no 0 yes 4 4 N 2
22 laxmi 40 F 51 53035 MNG STT 95 115 70 no 0 no 0 0 N 2
23 seetha 53 F 50 64064 MNG STT 95 120 70 yes 5 yes 5 10 Y 2
24 james 52 M 64 63375 MNG NTT 105 125 100 yes 4 yes 6 10 N 2
25 vellathai 36 F 47 64046 MNG NTT 90 110 80 no 0 no 0 0 N 2
26 prabha 36 F 54 62479 MNG TT 95 120 90 no 0 yes 5 5 N 2
27 chittammal 37 F 52 68742 MNG(T) TT 90 115 80 no 0 no 0 0 Y 2
28 chandrika 40 F 51 68756 MNG NTT 95 120 80 no 0 yes 4 4 N 2
29 karuppaih 47 M 56 79818A THYRO TT 120 140 75 no 0 no 0 0 Y 2
30 muthukumar 30 M 60 80640 MNG STT 110 135 90 no 0 no 0 0 N 2
STUDY GROUP - BSCPB WITH BUPIVACAINE
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